APLLTDPharmaceuticals
Alembic Pharmaceuticals Ltd — Balance Sheet
₹663.25
-2.97%
Alembic Pharmaceuticals Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Payables | 1.09K Cr | 912.26 Cr | 843.97 Cr | 926.35 Cr | — |
| Ordinary Shares Number | 19.66 Cr | 19.66 Cr | 19.66 Cr | 19.66 Cr | — |
| Share Issued | 19.66 Cr | 19.66 Cr | 19.66 Cr | 19.66 Cr | — |
| Net Debt | 1.11K Cr | 310.24 Cr | 560.38 Cr | 568.90 Cr | — |
| Total Debt | 1.26K Cr | 513.16 Cr | 722.01 Cr | 717.11 Cr | — |
| Tangible Book Value | 5.19K Cr | 4.82K Cr | 4.37K Cr | 5.08K Cr | — |
| Invested Capital | 6.39K Cr | 5.25K Cr | 5.01K Cr | 5.87K Cr | — |
| Working Capital | 1.68K Cr | 1.62K Cr | 1.27K Cr | 1.14K Cr | — |
| Net Tangible Assets | 5.19K Cr | 4.82K Cr | 4.37K Cr | 5.08K Cr | — |
| Capital Lease Obligations | 61.93 Cr | 82.71 Cr | 86.15 Cr | 87.12 Cr | — |
| Common Stock Equity | 5.19K Cr | 4.82K Cr | 4.37K Cr | 5.24K Cr | — |
| Total Capitalization | 5.19K Cr | 4.82K Cr | 4.37K Cr | 5.24K Cr | — |
| Total Equity Gross Minority Interest | 5.19K Cr | 4.82K Cr | 4.37K Cr | 5.24K Cr | — |
| Minority Interest | -1.42 Cr | 0.00 | — | 0.00 | -60.64 Cr |
| Stockholders Equity | 5.19K Cr | 4.82K Cr | 4.37K Cr | 5.24K Cr | — |
| Other Equity Interest | 5.15K Cr | 0.01 Cr | 4.33K Cr | 5.20K Cr | — |
| Retained Earnings | 4.39K Cr | 4.03K Cr | 3.57K Cr | 2.55K Cr | — |
| Additional Paid In Capital | 748.39 Cr | 748.39 Cr | 748.39 Cr | 798.39 Cr | — |
| Capital Stock | 39.31 Cr | 39.31 Cr | 39.31 Cr | 39.31 Cr | — |
| Common Stock | 39.31 Cr | 39.31 Cr | 39.31 Cr | 39.31 Cr | — |
| Total Liabilities Net Minority Interest | 2.58K Cr | 1.63K Cr | 1.81K Cr | 1.88K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 171.08 Cr | 172.38 Cr | 175.45 Cr | 167.95 Cr | — |
| Other Non Current Liabilities | 18.92 Cr | -0.01 Cr | 0.02 Cr | -0.01 Cr | — |
| Long Term Debt And Capital Lease Obligation | 46.77 Cr | 62.88 Cr | 69.23 Cr | 72.14 Cr | — |
| Long Term Capital Lease Obligation | 46.77 Cr | 62.88 Cr | 69.23 Cr | 72.14 Cr | — |
| Long Term Provisions | 124.31 Cr | 109.51 Cr | 106.20 Cr | 95.82 Cr | — |
| Current Liabilities | 2.41K Cr | 1.46K Cr | 1.64K Cr | 1.72K Cr | — |
| Other Current Liabilities | 0.03 Cr | 59.95 Cr | 85.54 Cr | -0.01 Cr | — |
| Current Debt And Capital Lease Obligation | 1.21K Cr | 450.28 Cr | 652.78 Cr | 644.97 Cr | — |
| Current Capital Lease Obligation | 15.16 Cr | 19.83 Cr | 16.92 Cr | 14.98 Cr | — |
| Current Debt | 1.20K Cr | 430.45 Cr | 635.86 Cr | 629.99 Cr | — |
| Current Provisions | 85.87 Cr | 65.25 Cr | 70.06 Cr | 63.64 Cr | — |
| Other Payable | 180.81 Cr | 170.67 Cr | 157.77 Cr | 213.55 Cr | — |
| Dividends Payable | 6.17 Cr | 5.95 Cr | 6.39 Cr | 6.41 Cr | — |
| Total Tax Payable | 18.91 Cr | 0.00 | — | 0.00 | 2.15 Cr |
| Accounts Payable | 879.89 Cr | 735.64 Cr | 679.81 Cr | 706.39 Cr | — |
| Total Assets | 7.77K Cr | 6.45K Cr | 6.18K Cr | 7.12K Cr | — |
| Total Non Current Assets | 3.69K Cr | 3.37K Cr | 3.27K Cr | 4.26K Cr | — |
| Other Non Current Assets | -0.72 Cr | 33.30 Cr | 53.74 Cr | -0.02 Cr | — |
| Non Current Prepaid Assets | 31.15 Cr | 33.30 Cr | 53.74 Cr | 34.88 Cr | — |
| Non Current Deferred Taxes Assets | 166.03 Cr | 169.64 Cr | 123.01 Cr | 5.88 Cr | — |
| Investmentin Financial Assets | 101.50 Cr | 68.62 Cr | 71.20 Cr | 63.69 Cr | — |
| Available For Sale Securities | 86.20 Cr | 50.30 Cr | 64.06 Cr | 63.69 Cr | — |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 15.30 Cr | 18.32 Cr | 7.14 Cr | 0.00 | — |
| Long Term Equity Investment | 25.71 Cr | 24.41 Cr | 25.13 Cr | 54.72 Cr | — |
| Investmentsin Joint Venturesat Cost | 0.53 Cr | 0.52 Cr | 0.51 Cr | 0.48 Cr | — |
| Investments In Other Ventures Under Equity Method | 25.72 Cr | — | — | — | 48.86 Cr |
| Investmentsin Associatesat Cost | 25.18 Cr | 23.89 Cr | 24.62 Cr | 54.24 Cr | — |
| Net PPE | 3.36K Cr | 3.07K Cr | 3.00K Cr | 3.95K Cr | — |
| Accumulated Depreciation | -1.59K Cr | -1.33K Cr | -1.07K Cr | -859.49 Cr | — |
| Gross PPE | 4.96K Cr | 4.40K Cr | 4.07K Cr | 4.81K Cr | — |
| Construction In Progress | 837.23 Cr | 524.36 Cr | 601.28 Cr | 2.21K Cr | — |
| Other Properties | 445.07 Cr | 437.22 Cr | 434.23 Cr | 404.52 Cr | — |
| Machinery Furniture Equipment | 2.62K Cr | 2.41K Cr | 2.06K Cr | 1.42K Cr | — |
| Buildings And Improvements | 925.30 Cr | 890.49 Cr | 835.00 Cr | 644.06 Cr | — |
| Land And Improvements | 127.43 Cr | 136.02 Cr | 136.44 Cr | 127.85 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 4.09K Cr | 3.08K Cr | 2.91K Cr | 2.86K Cr | — |
| Other Current Assets | -0.01 Cr | 221.81 Cr | 213.52 Cr | 0.02 Cr | — |
| Hedging Assets Current | 0.00 | 3.09 Cr | 0.00 | 14.57 Cr | — |
| Restricted Cash | 6.61 Cr | 6.36 Cr | 6.79 Cr | 8.34 Cr | — |
| Prepaid Assets | 298.77 Cr | 232.77 Cr | 223.37 Cr | 334.86 Cr | — |
| Inventory | 2.29K Cr | 1.64K Cr | 1.48K Cr | 1.61K Cr | — |
| Other Inventories | 199.07 Cr | 93.57 Cr | 68.93 Cr | 61.07 Cr | — |
| Finished Goods | 1.29K Cr | 1.05K Cr | 903.72 Cr | 968.75 Cr | — |
| Work In Process | 124.51 Cr | 69.52 Cr | 75.07 Cr | 88.68 Cr | — |
| Raw Materials | 677.67 Cr | 428.34 Cr | 427.55 Cr | 491.20 Cr | — |
| Taxes Receivable | 11.01 Cr | 41.03 Cr | 82.71 Cr | 25.08 Cr | — |
| Accounts Receivable | 1.40K Cr | 1.02K Cr | 1.05K Cr | 807.13 Cr | — |
| Allowance For Doubtful Accounts Receivable | -34.48 Cr | -35.59 Cr | -28.42 Cr | -33.33 Cr | — |
| Gross Accounts Receivable | 1.43K Cr | 1.06K Cr | 1.07K Cr | 840.46 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 83.48 Cr | 120.21 Cr | 75.48 Cr | 61.09 Cr | — |
| Other Short Term Investments | 18.15 Cr | 27.13 Cr | 16.64 Cr | 31.62 Cr | — |
| Cash And Cash Equivalents | 83.48 Cr | 120.21 Cr | 75.48 Cr | 61.09 Cr | — |
| Cash Financial | 83.48 Cr | 120.21 Cr | 75.48 Cr | 61.09 Cr | — |
| Investmentsin Subsidiariesat Cost | — | 0.45 Cr | 0.45 Cr | 0.45 Cr | 0.45 Cr |
| Goodwill And Other Intangible Assets | — | 0.00 | 0.00 | 154.82 Cr | 323.81 Cr |
| Other Receivables | — | 6.72 Cr | — | — | — |
| Non Current Deferred Taxes Liabilities | — | — | — | 0.00 | 4.21 Cr |
| Long Term Debt | — | — | — | 0.00 | 199.89 Cr |
| Other Intangible Assets | — | — | — | 154.82 Cr | 323.81 Cr |
| Goodwill | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Alembic Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.